RecruitingPhase 2NCT06081348

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Principal Investigator: Dr. Evdokia Anagnostou
Holland Bloorview Kids Rehab Hospital
Intervention: Sertraline(drug)
Enrollment: 130 enrolled
Eligibility: 8-17 years · All sexes
Timeline: 2024 – 2026

Study locations (8)

Alberta Children's Hospital - University of Calgary, Calgary, Alberta, Canada
University of Alberta-Glenrose, Edmonton, Alberta, Canada
Dalhousie University - IWK Health Centre, Halifax, Nova Scotia, Canada
McMaster University, Hamilton, Ontario, Canada
Queen's University, Kingston, Ontario, Canada
University of Western Ontario, Lawson Health Research Institute, London, Ontario, Canada
Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada
Ste Justine Hospital - Universite de Montreal, Montreal, Quebec, Canada

Collaborators

Azrieli Foundation (Funder) · Canadian Institutes of Health Research (Funder) · Ontario Brain Institute (Funder) · McMaster University · Western University · Queen's University · University of Alberta · Alberta Health services · St. Justine's Hospital · Dalhousie University · Unity Health Toronto · University of Toronto · The Hospital for Sick Children · Maternal, Infant, Child and Youth Research Network (MICYRN)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06081348 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome →

← Back to all trials